دورية أكاديمية
1477P STK11 mutations predict poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status
| العنوان: | 1477P STK11 mutations predict poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status |
|---|---|
| المؤلفون: | De Giglio, A., de Biase, D., Di Federico, A., Maloberti, T., Casadio, C., Gruppioni, E., Altimari, A., Melotti, B., Sperandi, F., Gelsomino, F., Ardizzoni, A. |
| المصدر: | In Annals of Oncology October 2023 34 Supplement 2:S836-S836 |
| قاعدة البيانات: | ScienceDirect |
| تدمد: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2023.09.2508 |